Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| PL2200 Aspirin Capsules | Investigational drug arm; crossover design PL2200 Aspirin Capsules: 325 mg aspirin; once per day for 3 days | None | None | 0 | 38 | 2 | 38 | View |
| Immediate-Release Aspirin Tablets | Active comparator; crossover design Immediate-Release Aspirin Tablets: 325 mg aspirin; once per day for 3 days | None | None | 0 | 40 | 4 | 40 | View |
| Enteric-coated Aspirin Caplets | Active comparator; crossover design Enteric-coated aspirin caplets: 325 mg aspirin; once per day for 3 days | None | None | 0 | 38 | 7 | 38 | View |